Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

1.9K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.9K
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

1.5K
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.5K
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

3.1K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
3.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

392
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
392
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

861
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
861

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subtyping binge-watchers based on viewing patterns and motives: A latent class analysis.

Acta psychologica·2026
Same author

Overcoming barriers to the prescription/dispensation of take-home naloxone among French primary care professionals: a regional training initiative.

European journal of public health·2026
Same author

From coming to terms with the gambling problems to post-traumatic growth: A novel nine-stage theoretical model of recovery from gambling disorder.

Journal of behavioral addictions·2026
Same author

Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction - META study protocol.

BMJ open·2026
Same author

A qualitative insight into the experience of slamming: A focus group study in western France.

Addictive behaviors·2026
Same author

Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019-2023.

Journal of psychopharmacology (Oxford, England)·2026

Related Experiment Video

Updated: Apr 30, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.9K

Benzodiazepines consumption: does dependence vary with age?

Marie Gérardin1, Caroline Victorri-Vigneau, Marylène Guerlais

  • 11Department of Clinical Pharmacology, University Hospital of Nantes, Nantes, France.

Substance Use & Misuse
|May 10, 2014
PubMed
Summary

Older adults (seniors) using benzodiazepines experience fewer negative consequences than younger adults. However, younger adults report higher consumption and more psychological issues, leading to greater dependence.

Keywords:
adultsagebenzodiazepinespharmacodependenceseniors

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.0K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K

Related Experiment Videos

Last Updated: Apr 30, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.9K
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.0K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K

Area of Science:

  • Gerontology
  • Psychopharmacology
  • Addiction Medicine

Background:

  • Chronic benzodiazepine use is prevalent across age groups.
  • Understanding age-related differences in benzodiazepine dependence is crucial for targeted interventions.
  • Previous research has not fully elucidated the distinct patterns of use and dependence between elderly and adult populations.

Purpose of the Study:

  • To compare benzodiazepine (including zolpidem/zopiclone) dependence and usage patterns in chronic users aged 65+ (Seniors) versus those under 65 (Adults).
  • To identify differences in negative consequences and psychological factors associated with benzodiazepine use in these two distinct age cohorts.

Main Methods:

  • A comparative study was conducted in the Pays de Loire region.
  • Data collection involved questionnaires assessing dependence based on DSM-IV criteria.
  • Analysis included 176 questionnaires from Seniors and 212 from Adults.

Main Results:

  • Seniors reported routine benzodiazepine use with fewer adverse effects compared to Adults.
  • Adults exhibited higher-than-planned consumption, underlying psychological distress, and more negative consequences.
  • Benzodiazepine dependence rates were 35.2% in Seniors versus 49.8% in Adults.

Conclusions:

  • Age significantly influences benzodiazepine use patterns and dependence severity.
  • Adults, compared to Seniors, face greater risks associated with chronic benzodiazepine use, including psychological distress and higher dependence rates.
  • Clinical approaches to benzodiazepine dependence should consider age-specific factors and potential co-occurring psychological conditions.